slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 99,331-99,360
Pages 3,950
Rows per page 30
Component
99,331-99,360 of 118,471
10
The slide explicitly labels the model as 'Razor/Razor Blade Economics'.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Business Model1 hit
11
Uses the 'Razor/Razor Blade' business model framework.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Business Model1 hit
16
The diagram uses concentric circles to represent clinical phases and color-coded dots to represent cell approaches (allogeneic vs autologous).MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
17
The slide uses a Vitruvian Man-style graphic to represent the breadth of therapeutic applications.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
19
MaxCyte | Investor Presentation Deck | 19 slidesMaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Loop · Why Now1 hit
03
The slide uses a dramatic, urgent tone to frame the problem.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The screenshot shows a glucose trend line over time with a specific reading of 7.5 mmol/L.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
15
The slide uses a numbered list format to present two distinct product expansion paths.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
07
Data presented as two pie charts.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
14
The slide highlights NYCB's position in the top quartile for adjusted CET1.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
16
The slide highlights the bank's focus on multi-family loans and its historical low loss rates.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Executive SummaryLoop · Golden Circle1 hit
27
Includes SBNY acquisition impact and prior acquisitions.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations 1 hit
01
Nexters | Investor Presentation Deck | 18 slidesNexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
03
Nexters | Investor Presentation Deck | 18 slidesNexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
06
The slide uses a consistent three-column layout to compare key performance metrics across three distinct game titles.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
09
Includes a breakdown of board members by status, expertise, and gender.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations Beat · Team1 hit
10
The slide uses a custom framework to categorize ESG initiatives.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
03
Nexters | Results Presentation Deck | 11 slidesNexters | Results Presentation Deck | 11 slides · GDEV Inc.
Conference presentation Investor relations 1 hit
01
Nuvalent | Investor Presentation Deck | 52 slidesNuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
Uses a Venn diagram to illustrate the intersection of solving for resistance and selectivity.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
07
Uses a before-after-bridge framework to contrast existing therapy failure with Nuvalent's success.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a visual comparison framework to contrast traditional non-selective kinase inhibitors with the company's selective approach.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a medical illustration to map specific TRK receptor inhibition side effects to anatomical locations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses dot plots to show IC50 values for different drugs across fusion partners and mutations, and a bar chart to show tumor regression efficacy.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
16
The slide details the patient population (N=35) and the subset of response-evaluable patients (N=21) across five dose cohorts.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
25
The slide uses a timeline-style list on the left to show treatment history and a visual 'before-and-after' comparison of medical imaging on the right.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
27
Includes clinical trial data cut-offs and patient enrollment numbers.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
28
The slide details specific patient cohorts (2a-2e) with varying treatment histories and trial objectives.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
32
The slide uses a split-panel layout to contrast in vitro IC50 data with in vivo tumor regression data.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
33
The slide uses a bar chart for brain penetrance and a scatter plot for selectivity index to demonstrate the drug's therapeutic profile.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit